Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Storage buffer||PBS, pH 7.4|
|Contains||0.09% sodium azide|
|Storage Conditions||4°C or -20°C if preferred|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Flow Cytometry (Flow)||1/50-1/100|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Clone NKVFS1 recognizes the long and short forms CD158a and CD158b (KIR2DL, KIR2DS1 and KIR2DS2 respectively) and also p50.3 (KIR2DS4). This clone is reported to have functional activity, activating NK cell cytotoxicity via KIR2DS and inhibiting via KIR2DL forms.
For FACS analysis, use 10ul of the suggested working dilution to label 1x10^6 cells in 100ul.
KIR2D family members are cell surface glycoproteins with two Ig domains, which are expressed on natural killer cells and some T cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
CD158; CD158 antigen-like family member A; CD158 antigen-like family member H; CD158 antigen-like family member I; CD158 antigen-like family member J; CD158a; CD158b; CD158B1; CD158B2; CD158H; CD158I; CD158J; killer cell immunoglobulin-like receptor 2DL1; killer cell immunoglobulin-like receptor KIR2DS2; killer cell immunoglobulin-like receptor KIRDS1; killer cell immunoglobulin-like receptor two domains short cytoplasmic tail 1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer Ig receptor; killer inhibitory receptor 2-2-1; killer inhibitory receptor 4-1-2; killer-cell Ig-like receptor; killer-cell immunoglobulin-like receptor; killer-cell immunoglobulin-like receptor two domains short tail 2 protein; KIR antigen 2DS4; KIR-K64; KIR221; KIR2DL; KIR2DS1; KIR2DS2; KIR2DS4; KIRCL23; KKA3; MHC class I NK cell receptor; MHC class I NK cell receptor Eb6 ActI; natural killer associated transcript 5; natural killer cell inhibitory receptor; natural killer-associated transcript 1; natural killer-associated transcript 8; NK receptor 183 ActI; NKAT; NKAT-1; NKAT1; NKAT2; NKAT5; NKAT6; NKAT8; p50 killer cell activating receptor KAR-K1d; p50.3; p58 killer cell inhibitory receptor KIR-K64; p58 killer cell inhibitory receptor KIR-K7a; p58 natural killer cell receptor clone CL-49; P58 natural killer cell receptor clones CL-39/CL-17; p58 natural killer cell receptor clones CL-42/47.11; p58 NK cell inhibitory receptor NKR-K6; p58 NK receptor CL-39/CL-17; p58 NK receptor CL-42/47.11; p58.1; p58.1 MHC class-I-specific NK receptor; XXbac-BCX195L8.1
183ActI; CD158A; CD158b; CD158H; CD158I; CD158J; cl-49; KIR-2DS2; KIR-2DS4; KIR-K64; KIR1D; KIR221; KIR2DL1; KIR2DP1DL1; KIR2DS1; KIR2DS2; KIR2DS4; KIR412; KKA3; NKAT; NKAT-1; NKAT-5; NKAT-8; NKAT1; NKAT5; NKAT8; p50.1; p58.1